References
- GradmanAHBasileJNCarterBLBakrisGLCombination therapy in hypertensionJ Clin Hypertens (Greenwich)201113314615421366845
- SeverPSMesserliFHHypertension management 2011: optimal combination therapyEur Heart J201132202499250621697169
- FranklinSSNeutelJMInitial combination therapy for rapid and effective control of moderate and severe hypertensionJ Hum Hypertens200923141118615100
- ChobanianAVBakrisGLBlackHRSeventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressureHypertension20034261206125214656957
- ManciaGDeBGDominiczakA2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)J Hypertens20072561105118717563527
- CorraoGNicotraFParodiACardiovascular protection by initial and subsequent combination of antihypertensive drugs in daily life practiceHypertension201158456657221825231
- BangaloreSLeyLImproving treatment adherence to antihypertensive therapy: the role of single-pill combinationsExpert Opin Pharmacother201213334535522220825
- PloskerGLWhiteWBTelmisartan/hydrochlorothiazide: a review of its use as fixed-dose combinations in essential hypertensionDrugs200868131877189918729541
- ZhuDLBaysHGaoPMattheusMVoelkerBRuilopeLMEfficacy and tolerability of initial therapy with single-pill combination telmisartan/hydrochlorothiazide 80/25 mg in patients with grade 2 or 3 hypertension: a multinational, randomized, double-blind, active-controlled trialClin Ther20123471613162422717420
- ChapmanABSchwartzGLBoerwinkleETurnerSTPredictors of antihypertensive response to a standard dose of hydrochlorothiazide for essential hypertensionKidney Int20026131047105511849460
- NeutelJMLong-term blood pressure control: what can we do?Postgrad Med20111231889321293088
- JohnsonJAEthnic differences in cardiovascular drug response: potential contribution of pharmacogeneticsCirculation2008118131383139318809808
- GuptaAKRacial differences in response to antihypertensive therapy: does one size fits all?Int J Prev Med20101421721921566775
- OfiliEOFerdinandKCSaundersEIrbesartan/HCTZ fixed combinations in patients of different racial/ethnic groups with uncontrolled systolic blood pressure on monotherapyJ Natl Med Assoc200698461862616623075
- CushmanWCNeutelJMSaundersEEfficacy and safety of fixed combinations of irbesartan/hydrochlorothiazide in older vs younger patients with hypertension uncontrolled with monotherapyAm J Geriatr Cardiol2008171273618174757
- OfiliEOCableGNeutelJMSaundersEEfficacy and safety of fixed combinations of irbesartan/hydrochlorothiazide in hypertensive women: the inclusive trialJ Womens Health (Larchmt)200817693193818681815
- NashDTCrikelairNZappeDAchieving BP goals with valsartan and HCTZ alone and in combination: pooled analysis of two randomized, double-blind, placebo-controlled studiesCurr Med Res Opin20082492617262618687165
- WhiteWBDavidaiGSchumacherHImpact of angiotensin receptor blockade in combination with hydrochlorothiazide 25 mg in 2121 patients with stage 1–2 hypertensionJ Hum Hypertens2009231281782519357698
- WeirMRRolfeMPotassium homeostasis and renin-angiotensin-aldosterone system inhibitorsClin J Am Soc Nephrol20105353154820150448
- KohKKQuonMJHanSHDistinct vascular and metabolic effects of different classes of anti-hypertensive drugsInt J Cardiol20101401738119059660
- SrivastavaTNYoungDBImpairment of cardiac function by moderate potassium depletionJ Card Fail1995131952009420651
- FranseLVPahorMDiBMSomesGWCushmanWCApplegateWBHypokalemia associated with diuretic use and cardiovascular events in the Systolic Hypertension in the Elderly ProgramHypertension20003551025103010818057
- HwangKSKimGHThiazide-induced hyponatremiaElectrolyte Blood Press201081515721468197
- SavagePJPresselSLCurbJDInfluence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: The Systolic Hypertension in the Elderly Program. SHEP Cooperative Research GroupArch Intern Med199815877417519554680
- BrandFNMcGeeDLKannelWBStokesJIIICastelliWPHyperuricemia as a risk factor of coronary heart disease: the Framingham StudyAm J Epidemiol1985121111183964986
- SowersJRRaijLJialalIAngiotensin receptor blocker/diuretic combination preserves insulin responses in obese hypertensivesJ Hypertens20102881761176920498618
- KalraSKalraBAgrawalNCombination therapy in hypertension: An updateDiabetol Metabol Syndr2010214454